Celltrion is suspending development an inhalable Covid-19 treatment, the company said Tuesday.
Hyundai Bioscience said Thursday Phase 1 clinical trials of its oral Covid-19 treatment produced meaningful results confirming its safety.
Hyundai Bioscience hopes to make an oral Covid-19 treatment that can also be used for treating the flu.
Celltrion’s Covid-19 treatment candidate has been approved for trials as a preventive treatment in Korea.
Korea JoongAng Daily Sitemap